150 Cyclists from Merck Millipore and Merck Serono Participated in 150 Mile Ride for MS

July 10, 2013, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck KGaA, participate in and sponsor the Bike MS: Cape Cod Getaway ride to raise money for Multiple Sclerosis (MS).  

Who:
Merck Millipore and Merck Serono, divisions of Merck KGaA of Darmstadt, Germany

What:   
Participants and sponsors for the Cape Cod Getaway

When:  
Saturday, June 29 and Sunday, June 30

Where: 
The 150 mile route runs from Boston-Provincetown, Massachusetts

Why:      
150 employees from Merck Millipore and Merck Serono participated in the Bike MS: Cape Cod Getaway event as part of team “Reason to Ride”. The two day, 150 mile ride started in Boston and ended in Provincetown, MA, attracting over 2,000 cyclists. This was the ninth year of participation for Merck Serono and Team “Reason to Ride.” As corporate sponsors of the event, employees from Merck Millipore and Merck Serono were encouraged to volunteer at rest stops along the route.

David Beattie, Senior R&D Director at Merck Millipore, has participated in MS Rides for 7 years, and has served as a captain of team “Reason to Ride” for 6 years. “People do this event for so many different reasons, which is how the team got its name,” says David. “I love the camaraderie of my team mates and other riders, the fantastic scenery, superb ride logistics and the amazing support we get from the community and the MS patients who come out to cheer us on. It’s my hope that our fundraising and few hours of hard work in the saddle can bring relief and encouragement to those who struggle every day.”

More than 400,000 people in North America live with MS. As a leading supplier of tools and technologies that support research for many chronic diseases including MS, Merck Millipore is proud to support the National Multiple Scleroses Society.

Fundraising totals can be viewed and additional donations made to team “Reason to Ride” here: http://bit.ly/ReasonToRide2013

About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany

About Merck Serono, INC:
Merck Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, endocrinology and in reproductive health. In addition, Merck Serono is growing its expertise and presence in the area of oncology, with more than 15 projects currently in development. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, Merck Serono’s US footprint continues to grow, with approximately 1,000 employees around the country and fully integrated commercial, clinical and research operations in the company’s home state of Massachusetts.